|
Table 14: Number of Cases and Percent of
First Primary Malignant Central Nervous System Tumors by Demographics and
Anatomic Site, 65 Years and Older, California, 2001-2005 |
||||||||||||||||||||||
|
Behavior |
Histology |
Sex |
|
Total |
|
NH White |
|
NH Black |
|
Hispanic |
|
API |
||||||||||
|
|
|
|
|
AAIR |
95% CI |
|
AAIR |
95% CI |
|
AAIR |
95% CI |
|
AAIR |
95% CI |
|
AAIR |
95% CI |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malignant |
Astrocytoma,
anaplastic |
Total |
|
0.8 |
0.7 |
0.9 |
|
0.9 |
0.8 |
1.1 |
|
|
|
|
|
0.7 |
0.4 |
1.0 |
|
0.5 |
0.2 |
0.9 |
|
|
|
Male |
|
0.9 |
0.7 |
1.2 |
|
1.1 |
0.9 |
1.4 |
|
0.0 |
0.0 |
1.1 |
|
0.6 |
0.3 |
1.3 |
|
0.6 |
0.2 |
1.4 |
|
|
|
Female |
|
0.7 |
0.6 |
0.9 |
|
0.8 |
0.6 |
1.0 |
|
|
|
|
|
0.7 |
0.4 |
1.2 |
|
0.4 |
0.1 |
0.9 |
|
|
Astrocytoma,
NOS |
Total |
|
0.6 |
0.5 |
0.7 |
|
0.6 |
0.5 |
0.8 |
|
|
|
|
|
0.9 |
0.6 |
1.3 |
|
0.3 |
0.1 |
0.7 |
|
|
|
Male |
|
0.7 |
0.5 |
0.9 |
|
0.7 |
0.5 |
1.0 |
|
|
|
|
|
1.0 |
0.5 |
1.8 |
|
|
|
|
|
|
|
Female |
|
0.6 |
0.4 |
0.7 |
|
0.6 |
0.4 |
0.8 |
|
|
|
|
|
0.8 |
0.4 |
1.4 |
|
|
|
|
|
|
Glioblastoma |
Total |
|
9.9 |
9.4 |
10.4 |
|
11.3 |
10.7 |
11.9 |
|
5.8 |
4.4 |
7.6 |
|
9.9 |
8.8 |
11.2 |
|
4.4 |
3.6 |
5.4 |
|
|
|
Male |
|
12.2 |
11.4 |
13.0 |
|
13.7 |
12.8 |
14.8 |
|
7.0 |
4.7 |
10.2 |
|
12.4 |
10.4 |
14.6 |
|
5.8 |
4.4 |
7.7 |
|
|
|
Female |
|
8.1 |
7.6 |
8.7 |
|
9.4 |
8.6 |
10.1 |
|
4.8 |
3.1 |
7.0 |
|
8.2 |
6.9 |
9.7 |
|
3.4 |
2.5 |
4.6 |
|
|
Oligodendroglioma |
Total |
|
0.2 |
0.1 |
0.2 |
|
0.2 |
0.1 |
0.3 |
|
|
|
|
|
0.2 |
0.1 |
0.4 |
|
|
|
|
|
|
|
Male |
|
0.2 |
0.1 |
0.3 |
|
0.3 |
0.1 |
0.4 |
|
0.0 |
0.0 |
1.1 |
|
|
|
|
|
|
|
|
|
|
|
Female |
|
0.1 |
0.1 |
0.2 |
|
0.2 |
0.1 |
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anaplastic
oligodendroglioma |
Total |
|
0.1 |
0.1 |
0.2 |
|
0.1 |
0.1 |
0.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Male |
|
0.1 |
0.1 |
0.2 |
|
0.1 |
0.0 |
0.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
0.1 |
0.1 |
0.2 |
|
0.2 |
0.1 |
0.3 |
|
0.0 |
0.0 |
0.6 |
|
|
|
|
|
|
|
|
|
|
Ependymomas,
anaplastic |
Total |
|
0.2 |
0.1 |
0.3 |
|
0.2 |
0.1 |
0.3 |
|
|
|
|
|
0.2 |
0.1 |
0.5 |
|
|
|
|
|
|
|
Male |
|
0.2 |
0.1 |
0.4 |
|
0.3 |
0.1 |
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
0.2 |
0.1 |
0.3 |
|
0.1 |
0.1 |
0.3 |
|
|
|
|
|
0.3 |
0.1 |
0.7 |
|
|
|
|
|
|
Mixed
glioma |
Total |
|
0.1 |
0.1 |
0.2 |
|
0.2 |
0.1 |
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Male |
|
0.2 |
0.1 |
0.3 |
|
0.2 |
0.1 |
0.4 |
|
0.0 |
0.0 |
1.1 |
|
|
|
|
|
|
|
|
|
|
|
Female |
|
0.1 |
0.1 |
0.2 |
|
0.1 |
0.1 |
0.2 |
|
|
|
|
|
0.0 |
0.0 |
0.2 |
|
|
|
|
|
|
Glioma
malignant, NOS |
Total |
|
0.8 |
0.7 |
0.9 |
|
0.8 |
0.7 |
1.0 |
|
1.0 |
0.4 |
1.8 |
|
0.7 |
0.4 |
1.1 |
|
0.4 |
0.2 |
0.8 |
|
|
|
Male |
|
1.0 |
0.8 |
1.2 |
|
1.0 |
0.8 |
1.3 |
|
|
|
|
|
1.0 |
0.5 |
1.9 |
|
0.7 |
0.3 |
1.6 |
|
|
|
Female |
|
0.7 |
0.5 |
0.8 |
|
0.7 |
0.5 |
0.9 |
|
0.9 |
0.3 |
2.1 |
|
0.5 |
0.2 |
1.0 |
|
|
|
|
|
|
PNET/Meduloblastoma |
Total |
|
|
|
|
|
|
|
|
|
0.0 |
0.0 |
0.4 |
|
|
|
|
|
0.0 |
0.0 |
0.2 |
|
|
|
Male |
|
|
|
|
|
|
|
|
|
0.0 |
0.0 |
1.1 |
|
|
|
|
|
0.0 |
0.0 |
0.4 |
|
|
|
Female |
|
|
|
|
|
0.0 |
0.0 |
0.1 |
|
0.0 |
0.0 |
0.6 |
|
0.0 |
0.0 |
0.2 |
|
0.0 |
0.0 |
0.3 |
|
|
Lymphomas |
Total |
|
1.5 |
1.3 |
1.7 |
|
1.5 |
1.3 |
1.7 |
|
0.9 |
0.4 |
1.7 |
|
1.3 |
0.9 |
1.8 |
|
2.0 |
1.4 |
2.7 |
|
|
|
Male |
|
1.6 |
1.3 |
1.9 |
|
1.7 |
1.3 |
2.0 |
|
|
|
|
|
1.3 |
0.7 |
2.1 |
|
2.3 |
1.4 |
3.5 |
|
|
|
Female |
|
1.4 |
1.2 |
1.7 |
|
1.4 |
1.1 |
1.7 |
|
1.2 |
0.5 |
2.5 |
|
1.4 |
0.8 |
2.1 |
|
1.7 |
1.1 |
2.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benign |
Pilocytic
astrocytoma |
Total |
|
|
|
|
|
0.0 |
0.0 |
0.1 |
|
0.0 |
0.0 |
0.4 |
|
|
|
|
|
0.0 |
0.0 |
0.2 |
|
|
|
Male |
|
|
|
|
|
|
|
|
|
0.0 |
0.0 |
1.1 |
|
|
|
|
|
0.0 |
0.0 |
0.4 |
|
|
|
Female |
|
|
|
|
|
|
|
|
|
0.0 |
0.0 |
0.6 |
|
0.0 |
0.0 |
0.2 |
|
0.0 |
0.0 |
0.3 |
|
|
Nerve
sheath |
Total |
|
2.4 |
2.2 |
2.7 |
|
2.5 |
2.3 |
2.8 |
|
1.3 |
0.7 |
2.2 |
|
1.7 |
1.2 |
2.2 |
|
2.7 |
2.1 |
3.5 |
|
|
|
Male |
|
2.9 |
2.5 |
3.3 |
|
2.9 |
2.4 |
3.3 |
|
1.4 |
0.5 |
3.0 |
|
1.8 |
1.1 |
2.7 |
|
4.0 |
2.9 |
5.6 |
|
|
|
Female |
|
2.1 |
1.8 |
2.4 |
|
2.3 |
2.0 |
2.7 |
|
1.1 |
0.4 |
2.3 |
|
1.6 |
1.0 |
2.3 |
|
1.7 |
1.1 |
2.6 |
|
|
Meningioma |
Total |
|
17.8 |
17.2 |
18.4 |
|
17.8 |
17.1 |
18.6 |
|
20.3 |
17.5 |
23.4 |
|
16.3 |
14.8 |
17.9 |
|
17.8 |
16.0 |
19.7 |
|
|
|
Male |
|
11.9 |
11.2 |
12.7 |
|
12.3 |
11.4 |
13.3 |
|
15.6 |
11.7 |
20.3 |
|
9.5 |
7.7 |
11.5 |
|
10.4 |
8.4 |
12.8 |
|
|
|
Female |
|
22.2 |
21.3 |
23.1 |
|
22.1 |
21.0 |
23.2 |
|
23.2 |
19.5 |
27.5 |
|
21.1 |
18.9 |
23.5 |
|
23.2 |
20.6 |
26.0 |
|
|
Pituitary
tumors |
Total |
|
4.3 |
4.0 |
4.6 |
|
3.4 |
3.1 |
3.8 |
|
9.7 |
7.9 |
11.9 |
|
5.6 |
4.7 |
6.5 |
|
4.8 |
4.0 |
5.9 |
|
|
|
Male |
|
6.0 |
5.5 |
6.6 |
|
4.9 |
4.4 |
5.6 |
|
14.8 |
11.1 |
19.3 |
|
7.9 |
6.5 |
9.7 |
|
6.1 |
4.6 |
7.9 |
|
|
|
Female |
|
2.9 |
2.6 |
3.2 |
|
2.2 |
1.9 |
2.6 |
|
6.6 |
4.6 |
9.0 |
|
3.7 |
2.9 |
4.8 |
|
3.9 |
2.9 |
5.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
Age-adjusted incidence rates are per 100,000 population. Rates are standardized to the 2000 US
population. |
|
|
|
|
|
|
|
|
|
|||||||||||||